BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25070663)

  • 21. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
    Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
    Hanekamp EE; Gielen SC; Smid-Koopman E; Kühne LC; de Ruiter PE; Chadha-Ajwani S; Brinkmann AO; Grootegoed JA; Burger CW; Huikeshoven FJ; Blok LJ
    Clin Cancer Res; 2003 Sep; 9(11):4190-9. PubMed ID: 14519645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA-2 inhibits transforming growth factor-β signaling pathway through interaction with Smad4.
    Dong XM; Yin RH; Yang Y; Feng ZW; Ning HM; Dong L; Zheng WW; Tang LJ; Wang J; Jia YX; Jiang YN; Liu ED; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Yang XM
    Cell Signal; 2014 May; 26(5):1089-97. PubMed ID: 24509415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
    Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
    J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Siegesbeckia orientalis Extract Inhibits TGFβ1-Induced Migration and Invasion of Endometrial Cancer Cells.
    Chang CC; Ling XH; Hsu HF; Wu JM; Wang CP; Yang JF; Fang LW; Houng JY
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27527140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
    Tanaka T; Toujima S; Umesaki N
    Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
    Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Lazor JW; Sperry J; Jin C; Cao L; Freeman JW
    Cancer Res; 2008 Jun; 68(11):4221-8. PubMed ID: 18519681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.
    Monge M; Colas E; Doll A; Gil-Moreno A; Castellvi J; Diaz B; Gonzalez M; Lopez-Lopez R; Xercavins J; Carreras R; Alameda F; Canals F; Gabrielli F; Reventos J; Abal M
    Carcinogenesis; 2009 Aug; 30(8):1288-97. PubMed ID: 19443906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cathepsin D and prostate specific antigen on latent transforming growth factor-beta in breast cancer cell lines.
    Wong SF; Seow HF; Lai LC
    Malays J Pathol; 2003 Dec; 25(2):129-34. PubMed ID: 16196369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells.
    Cals FL; Hellingman CA; Koevoet W; Baatenburg de Jong RJ; van Osch GJ
    J Tissue Eng Regen Med; 2012 Jan; 6(1):68-76. PubMed ID: 21305699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of estrogen, progestin and mifepristone on endometrial carcinoma cell lines].
    Lu Y; Yu L; Chen CL; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):284-6. PubMed ID: 15968321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y; Tong J; Ai Z; Wang J; Teng Y
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.